Alvotech
Entwicklung und Herstellung von Biosimilars
Alvotech entwickelt und produziert Biosimilars für die Indikationen Autoimmunerkrankungen, Augenheilkunde und Onkologie. Die Anlage befindet sich in Reykjavik, Island.
- Type
- manufacturer (our classification of the record, not a statement by the company)
- Role
- Manufacturer
- Location
- Reykjavik, Iceland
- Website
- https://alvotech.com
- Categories
- Pharmazeutische Produktion
- Markets
- Island
What is established and what is not
No facet of this company has been investigated yet. The facts below are collected records, not an assessment: nothing here confirms manufacturing, ownership or trading status beyond what each record literally says.
Verified facts
- domain-registered (green), checked 2026-08-04 Domain registry record
- web-presence-since (green), checked 2026-08-02 Internet Archive (Wayback)
- lei-active (green), checked 2026-08-04 GLEIF
- sanctions-clear (green), checked 2026-08-04 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- debarment-clear (green), checked 2026-08-04 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- corporate-mail-on-domain (green), checked 2026-08-04 Mail server of the company domain
Import rules for these goods
- Medicines imported into the EU must come from a site holding an EU GMP certificate, and the importer needs a manufacturing/import authorisation. European Medicines Agency (GMP)